Research
A study released in October 2006 shows an increased risk of heart attacks in people with psoriasis. The risk was highest in young patients with severe psoriasis.
Drug Research
Results from a Phase III (late-stage) study show that adalimumab (Humira) is more effective than methotrexate in the treatment of moderate-to-severe psoriasis. In the study, 80% of patients treated for 16 weeks with adalimumab reported a 75% or better improvement, compared with 36% of patients treated with ...
Read more »... Today, there are basically five categories or classifications of drugs to treat Crohn's... Read more »
...Ulcerative Colitis fall into five categories, or classifications:1. Aminosalicylates or... Read more »
(Ivanhoe Newswire) -- The growing number of overweight or obese people isn't restricted to the United States; it's a problem worldwide. Data... Read summary »
(Ivanhoe Newswire) -- Nicotine addiction has reached its highest level within the last 15 years. Almost 75 percent of people currently being treated... Read summary »
(Ivanhoe Newswire) ? Light to moderate alcohol intake in older adults with normal cognition may lower the risk of dementia. Kaycee Sink, MD, MAS,... Read summary »
(Ivanhoe Newswire) Don't worry! Be happy! Optimistic women have a lower risk of developing heart disease or dying from any cause compared to... Read summary »
Drugmaker Abbott has launched Humira for the treatment of Crohn's disease in the United Kingdom. In April, the European Medicines Agency recommended... Read summary »